Cosette Pharmaceuticals Inc., a Bridgewater company that focuses on women’s health and cardiovascular medicines, announced June 8 it completed the acquisition of the global rights to Intrarosa from ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

BRIDGEWATER, N.J., December 16, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

BRIDGEWATER, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- Cosette Pharmaceuticals, Inc. (“Cosette” or the “Company”), a privately held specialty generic pharmaceutical company primarily focused on extended ...

Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sales and distribution rights for a ...

Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today that it has appointed ...

In this critical role, Jeff will lead Cosette’s best-in-class quality and regulatory affairs organizations, maintaining the company’s rigorous quality standards and further establishing Cosette’s ...

Apurva Saraf, President and CEO of Cosette Pharma, stated, "This is a pivotal product approval, and a testament to our unwavering dedication to R&D, operational excellence and innovation. This is ...

Cosette Coalhearth is an Engineer in Class G and along with Avan, Zeri and Aliasse, is one of the core members of the game. Cosette is shown as having a clumsy personality, but is also kind at heart.

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S.